4//SEC Filing
ZELDIS JEROME B 4
Accession 0001415889-24-028287
CIK 0001070081other
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 5:20 PM ET
Size
20.4 KB
Accession
0001415889-24-028287
Insider Transaction Report
Form 4
ZELDIS JEROME B
Director
Transactions
- Exercise/Conversion
Common Stock
2024-12-02$51.00/sh+12,000$612,000→ 26,500 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-12-02−12,000→ 0 totalExercise: $51.00Exp: 2025-01-02→ Common Stock (12,000 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2024-12-02−12,000→ 0 totalExercise: $30.86Exp: 2026-01-03→ Common Stock (12,000 underlying) - Sale
Common Stock
2024-12-02$52.42/sh−3,187$167,063→ 14,500 total - Sale
Common Stock
2024-12-02$51.44/sh−8,813$453,341→ 17,687 total - Sale
Common Stock
2024-12-02$52.39/sh−3,667$192,114→ 14,500 total - Exercise/Conversion
Common Stock
2024-12-02$30.86/sh+12,000$370,320→ 26,500 total - Sale
Common Stock
2024-12-02$50.52/sh−5,699$287,913→ 20,801 total - Sale
Common Stock
2024-12-02$51.43/sh−2,634$135,467→ 18,167 total
Footnotes (7)
- [F1]This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on May 22, 2024
- [F2]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $51.10 to $52.09 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F3]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $52.10 to $52.91 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F4]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $50.00 to 50.995 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F5]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $51.00 to $51.86 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F6]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $52.02 to $52.91 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F7]Currently exercisable.
Documents
Issuer
PTC THERAPEUTICS, INC.
CIK 0001070081
Entity typeother
Related Parties
1- filerCIK 0001433982
Filing Metadata
- Form type
- 4
- Filed
- Dec 3, 7:00 PM ET
- Accepted
- Dec 4, 5:20 PM ET
- Size
- 20.4 KB